Pharma & Healthcare
Global Contract Pharmaceutical Manufacturing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 285475
- Pages: 157
- Figures: 160
- Views: 30
In 2024, the global market size of Contract Pharmaceutical Manufacturing was estimated to be worth US$ 97880 million and is forecast to reach approximately US$ 145390 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Pharmaceutical Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Pharmaceutical Manufacturing.
The Contract Pharmaceutical Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contract Pharmaceutical Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Pharmaceutical Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Large Enterprise
Small Medium Enterprise
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Contract Pharmaceutical Manufacturing in global and regional level.
Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturing revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Pharmaceutical Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Pharmaceutical Manufacturing.
The Contract Pharmaceutical Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contract Pharmaceutical Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Pharmaceutical Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Large Enterprise
Small Medium Enterprise
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Contract Pharmaceutical Manufacturing in global and regional level.
Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturing revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Contract Pharmaceutical Manufacturing Product Introduction
1.2 Market by Type
1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Large Enterprise
1.3.3 Small Medium Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Contract Pharmaceutical Manufacturing Market Size Estimates and Forecasts
2.2 Contract Pharmaceutical Manufacturing Market Size by Region: 2024 Versus 2031
2.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Region: 2020-2025
2.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2026-2031)
2.2.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Contract Pharmaceutical Manufacturing Revenue by Type (2020-2031)
3.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Application (2020-2031)
3.2.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Oral of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
3.3.2 Injectable of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
3.3.3 API of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
3.3.4 Other of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
4 Global Contract Pharmaceutical Manufacturing by Company
4.1 Global Contract Pharmaceutical Manufacturing Revenue by Company (2020-2025)
4.2 Global Contract Pharmaceutical Manufacturing Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Contract Pharmaceutical Manufacturing Companies around the World: Ranking by Revenue
4.3.2 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Contract Pharmaceutical Manufacturing Companies Headquarters & Product Type
4.4.1 Global Contract Pharmaceutical Manufacturing Companies Headquarters
4.4.2 Date of International Companies Enter into Contract Pharmaceutical Manufacturing Market
4.4.3 Global Contract Pharmaceutical Manufacturing Companies Product & Service
4.4.4 Oral Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.4.5 Injectable Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.4.6 API Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.4.7 Other Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.5 Global Contract Pharmaceutical Manufacturing Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Catalent
5.1.1 Catalent Corporation Information
5.1.2 Catalent Description, Business Overview
5.1.3 Catalent Contract Pharmaceutical Manufacturing Products Offered
5.1.4 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.1.5 Catalent Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.1.6 Catalent Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.1.7 Catalent Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.1.8 Catalent Recent Developments
5.2 DPx
5.2.1 DPx Corporation Information
5.2.2 DPx Description, Business Overview
5.2.3 DPx Contract Pharmaceutical Manufacturing Products Offered
5.2.4 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.2.5 DPx Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.2.6 DPx Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.2.7 DPx Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.2.8 DPx Recent Developments
5.3 Lonza
5.3.1 Lonza Corporation Information
5.3.2 Lonza Description, Business Overview
5.3.3 Lonza Contract Pharmaceutical Manufacturing Products Offered
5.3.4 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.3.5 Lonza Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.3.6 Lonza Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.3.7 Lonza Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.3.8 Lonza Recent Developments
5.4 Piramal Healthcare
5.4.1 Piramal Healthcare Corporation Information
5.4.2 Piramal Healthcare Description, Business Overview
5.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Products Offered
5.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.4.5 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.4.6 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.4.7 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.4.8 Piramal Healthcare Recent Developments
5.5 Aenova
5.5.1 Aenova Corporation Information
5.5.2 Aenova Description, Business Overview
5.5.3 Aenova Contract Pharmaceutical Manufacturing Products Offered
5.5.4 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.5.5 Aenova Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.5.6 Aenova Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.5.7 Aenova Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.5.8 Aenova Recent Developments
5.6 Jubilant
5.6.1 Jubilant Corporation Information
5.6.2 Jubilant Description, Business Overview
5.6.3 Jubilant Contract Pharmaceutical Manufacturing Products Offered
5.6.4 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.6.5 Jubilant Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.6.6 Jubilant Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.6.7 Jubilant Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.6.8 Jubilant Recent Developments
5.7 Famar
5.7.1 Famar Corporation Information
5.7.2 Famar Description, Business Overview
5.7.3 Famar Contract Pharmaceutical Manufacturing Products Offered
5.7.4 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.7.5 Famar Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.7.6 Famar Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.7.7 Famar Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.7.8 Famar Recent Developments
5.8 Boehringer Ingelheim
5.8.1 Boehringer Ingelheim Corporation Information
5.8.2 Boehringer Ingelheim Description, Business Overview
5.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products Offered
5.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.8.5 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.8.6 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.8.7 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.8.8 Boehringer Ingelheim Recent Developments
5.9 Fareva Holding
5.9.1 Fareva Holding Corporation Information
5.9.2 Fareva Holding Description, Business Overview
5.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Products Offered
5.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.9.5 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.9.6 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.9.7 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.9.8 Fareva Holding Recent Developments
5.10 AbbVie
5.10.1 AbbVie Corporation Information
5.10.2 AbbVie Description, Business Overview
5.10.3 AbbVie Contract Pharmaceutical Manufacturing Products Offered
5.10.4 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.10.5 AbbVie Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.10.6 AbbVie Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.10.7 AbbVie Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.10.8 AbbVie Recent Developments
5.11 Nipro Corp
5.11.1 Nipro Corp Corporation Information
5.11.2 Nipro Corp Description, Business Overview
5.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Products Offered
5.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.11.5 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.11.6 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.11.7 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.11.8 Nipro Corp Recent Developments
5.12 Vetter
5.12.1 Vetter Corporation Information
5.12.2 Vetter Description, Business Overview
5.12.3 Vetter Contract Pharmaceutical Manufacturing Products Offered
5.12.4 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.12.5 Vetter Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.12.6 Vetter Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.12.7 Vetter Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.12.8 Vetter Recent Developments
5.13 Sopharma
5.13.1 Sopharma Corporation Information
5.13.2 Sopharma Description, Business Overview
5.13.3 Sopharma Contract Pharmaceutical Manufacturing Products Offered
5.13.4 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.13.5 Sopharma Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.13.6 Sopharma Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.13.7 Sopharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.13.8 Sopharma Recent Developments
5.14 DPT Laboratories
5.14.1 DPT Laboratories Corporation Information
5.14.2 DPT Laboratories Description, Business Overview
5.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Products Offered
5.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.14.5 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.14.6 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.14.7 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.14.8 DPT Laboratories Recent Developments
5.15 Recipharm
5.15.1 Recipharm Corporation Information
5.15.2 Recipharm Description, Business Overview
5.15.3 Recipharm Contract Pharmaceutical Manufacturing Products Offered
5.15.4 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.15.5 Recipharm Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.15.6 Recipharm Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.15.7 Recipharm Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.15.8 Recipharm Recent Developments
5.16 NextPharma
5.16.1 NextPharma Corporation Information
5.16.2 NextPharma Description, Business Overview
5.16.3 NextPharma Contract Pharmaceutical Manufacturing Products Offered
5.16.4 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.16.5 NextPharma Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.16.6 NextPharma Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.16.7 NextPharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.16.8 NextPharma Recent Developments
5.17 Dishman
5.17.1 Dishman Corporation Information
5.17.2 Dishman Description, Business Overview
5.17.3 Dishman Contract Pharmaceutical Manufacturing Products Offered
5.17.4 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.17.5 Dishman Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.17.6 Dishman Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.17.7 Dishman Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.17.8 Dishman Recent Developments
5.18 Aesica
5.18.1 Aesica Corporation Information
5.18.2 Aesica Description, Business Overview
5.18.3 Aesica Contract Pharmaceutical Manufacturing Products Offered
5.18.4 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.18.5 Aesica Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.18.6 Aesica Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.18.7 Aesica Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.18.8 Aesica Recent Developments
6 North America
6.1 North America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
6.2 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
6.3 North America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
6.4 North America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
7.4 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
8 Europe
8.1 Europe Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
8.2 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
8.3 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
8.4 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
9.2 Latin America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
9.3 Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
9.4 Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
10.4 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Contract Pharmaceutical Manufacturing Supply Chain Analysis
11.2 Contract Pharmaceutical Manufacturing Key Raw Materials and Upstream Suppliers
11.3 Contract Pharmaceutical Manufacturing Clients Analysis
11.4 Contract Pharmaceutical Manufacturing Sales Channel and Sales Model Analysis
11.4.1 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Contract Pharmaceutical Manufacturing Distributors
12 Contract Pharmaceutical Manufacturing Market Dynamics
12.1 Contract Pharmaceutical Manufacturing Industry Trends
12.2 Contract Pharmaceutical Manufacturing Market Drivers
12.3 Contract Pharmaceutical Manufacturing Market Challenges
12.4 Contract Pharmaceutical Manufacturing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Contract Pharmaceutical Manufacturing Product Introduction
1.2 Market by Type
1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Large Enterprise
1.3.3 Small Medium Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Contract Pharmaceutical Manufacturing Market Size Estimates and Forecasts
2.2 Contract Pharmaceutical Manufacturing Market Size by Region: 2024 Versus 2031
2.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Region: 2020-2025
2.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2026-2031)
2.2.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Contract Pharmaceutical Manufacturing Revenue by Type (2020-2031)
3.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Application (2020-2031)
3.2.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Oral of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
3.3.2 Injectable of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
3.3.3 API of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
3.3.4 Other of Contract Pharmaceutical Manufacturing Revenue Market Share by Application
4 Global Contract Pharmaceutical Manufacturing by Company
4.1 Global Contract Pharmaceutical Manufacturing Revenue by Company (2020-2025)
4.2 Global Contract Pharmaceutical Manufacturing Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Contract Pharmaceutical Manufacturing Companies around the World: Ranking by Revenue
4.3.2 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Contract Pharmaceutical Manufacturing Companies Headquarters & Product Type
4.4.1 Global Contract Pharmaceutical Manufacturing Companies Headquarters
4.4.2 Date of International Companies Enter into Contract Pharmaceutical Manufacturing Market
4.4.3 Global Contract Pharmaceutical Manufacturing Companies Product & Service
4.4.4 Oral Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.4.5 Injectable Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.4.6 API Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.4.7 Other Revenue Market Share of Contract Pharmaceutical Manufacturing by Company
4.5 Global Contract Pharmaceutical Manufacturing Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Catalent
5.1.1 Catalent Corporation Information
5.1.2 Catalent Description, Business Overview
5.1.3 Catalent Contract Pharmaceutical Manufacturing Products Offered
5.1.4 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.1.5 Catalent Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.1.6 Catalent Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.1.7 Catalent Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.1.8 Catalent Recent Developments
5.2 DPx
5.2.1 DPx Corporation Information
5.2.2 DPx Description, Business Overview
5.2.3 DPx Contract Pharmaceutical Manufacturing Products Offered
5.2.4 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.2.5 DPx Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.2.6 DPx Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.2.7 DPx Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.2.8 DPx Recent Developments
5.3 Lonza
5.3.1 Lonza Corporation Information
5.3.2 Lonza Description, Business Overview
5.3.3 Lonza Contract Pharmaceutical Manufacturing Products Offered
5.3.4 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.3.5 Lonza Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.3.6 Lonza Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.3.7 Lonza Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.3.8 Lonza Recent Developments
5.4 Piramal Healthcare
5.4.1 Piramal Healthcare Corporation Information
5.4.2 Piramal Healthcare Description, Business Overview
5.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Products Offered
5.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.4.5 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.4.6 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.4.7 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.4.8 Piramal Healthcare Recent Developments
5.5 Aenova
5.5.1 Aenova Corporation Information
5.5.2 Aenova Description, Business Overview
5.5.3 Aenova Contract Pharmaceutical Manufacturing Products Offered
5.5.4 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.5.5 Aenova Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.5.6 Aenova Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.5.7 Aenova Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.5.8 Aenova Recent Developments
5.6 Jubilant
5.6.1 Jubilant Corporation Information
5.6.2 Jubilant Description, Business Overview
5.6.3 Jubilant Contract Pharmaceutical Manufacturing Products Offered
5.6.4 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.6.5 Jubilant Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.6.6 Jubilant Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.6.7 Jubilant Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.6.8 Jubilant Recent Developments
5.7 Famar
5.7.1 Famar Corporation Information
5.7.2 Famar Description, Business Overview
5.7.3 Famar Contract Pharmaceutical Manufacturing Products Offered
5.7.4 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.7.5 Famar Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.7.6 Famar Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.7.7 Famar Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.7.8 Famar Recent Developments
5.8 Boehringer Ingelheim
5.8.1 Boehringer Ingelheim Corporation Information
5.8.2 Boehringer Ingelheim Description, Business Overview
5.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products Offered
5.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.8.5 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.8.6 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.8.7 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.8.8 Boehringer Ingelheim Recent Developments
5.9 Fareva Holding
5.9.1 Fareva Holding Corporation Information
5.9.2 Fareva Holding Description, Business Overview
5.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Products Offered
5.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.9.5 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.9.6 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.9.7 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.9.8 Fareva Holding Recent Developments
5.10 AbbVie
5.10.1 AbbVie Corporation Information
5.10.2 AbbVie Description, Business Overview
5.10.3 AbbVie Contract Pharmaceutical Manufacturing Products Offered
5.10.4 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.10.5 AbbVie Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.10.6 AbbVie Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.10.7 AbbVie Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.10.8 AbbVie Recent Developments
5.11 Nipro Corp
5.11.1 Nipro Corp Corporation Information
5.11.2 Nipro Corp Description, Business Overview
5.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Products Offered
5.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.11.5 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.11.6 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.11.7 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.11.8 Nipro Corp Recent Developments
5.12 Vetter
5.12.1 Vetter Corporation Information
5.12.2 Vetter Description, Business Overview
5.12.3 Vetter Contract Pharmaceutical Manufacturing Products Offered
5.12.4 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.12.5 Vetter Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.12.6 Vetter Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.12.7 Vetter Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.12.8 Vetter Recent Developments
5.13 Sopharma
5.13.1 Sopharma Corporation Information
5.13.2 Sopharma Description, Business Overview
5.13.3 Sopharma Contract Pharmaceutical Manufacturing Products Offered
5.13.4 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.13.5 Sopharma Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.13.6 Sopharma Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.13.7 Sopharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.13.8 Sopharma Recent Developments
5.14 DPT Laboratories
5.14.1 DPT Laboratories Corporation Information
5.14.2 DPT Laboratories Description, Business Overview
5.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Products Offered
5.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.14.5 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.14.6 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.14.7 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.14.8 DPT Laboratories Recent Developments
5.15 Recipharm
5.15.1 Recipharm Corporation Information
5.15.2 Recipharm Description, Business Overview
5.15.3 Recipharm Contract Pharmaceutical Manufacturing Products Offered
5.15.4 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.15.5 Recipharm Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.15.6 Recipharm Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.15.7 Recipharm Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.15.8 Recipharm Recent Developments
5.16 NextPharma
5.16.1 NextPharma Corporation Information
5.16.2 NextPharma Description, Business Overview
5.16.3 NextPharma Contract Pharmaceutical Manufacturing Products Offered
5.16.4 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.16.5 NextPharma Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.16.6 NextPharma Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.16.7 NextPharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.16.8 NextPharma Recent Developments
5.17 Dishman
5.17.1 Dishman Corporation Information
5.17.2 Dishman Description, Business Overview
5.17.3 Dishman Contract Pharmaceutical Manufacturing Products Offered
5.17.4 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.17.5 Dishman Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.17.6 Dishman Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.17.7 Dishman Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.17.8 Dishman Recent Developments
5.18 Aesica
5.18.1 Aesica Corporation Information
5.18.2 Aesica Description, Business Overview
5.18.3 Aesica Contract Pharmaceutical Manufacturing Products Offered
5.18.4 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2020-2025)
5.18.5 Aesica Contract Pharmaceutical Manufacturing Revenue by Product in 2024
5.18.6 Aesica Contract Pharmaceutical Manufacturing Revenue by Application in 2024
5.18.7 Aesica Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2024
5.18.8 Aesica Recent Developments
6 North America
6.1 North America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
6.2 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
6.3 North America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
6.4 North America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
7.4 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
8 Europe
8.1 Europe Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
8.2 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
8.3 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
8.4 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
9.2 Latin America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
9.3 Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
9.4 Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025)
10.4 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Contract Pharmaceutical Manufacturing Supply Chain Analysis
11.2 Contract Pharmaceutical Manufacturing Key Raw Materials and Upstream Suppliers
11.3 Contract Pharmaceutical Manufacturing Clients Analysis
11.4 Contract Pharmaceutical Manufacturing Sales Channel and Sales Model Analysis
11.4.1 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Contract Pharmaceutical Manufacturing Distributors
12 Contract Pharmaceutical Manufacturing Market Dynamics
12.1 Contract Pharmaceutical Manufacturing Industry Trends
12.2 Contract Pharmaceutical Manufacturing Market Drivers
12.3 Contract Pharmaceutical Manufacturing Market Challenges
12.4 Contract Pharmaceutical Manufacturing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Contract Pharmaceutical Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Contract Pharmaceutical Manufacturing Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Contract Pharmaceutical Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Contract Pharmaceutical Manufacturing Revenue by Company (2020-2025) & (US$ Million)
Table 11. Contract Pharmaceutical Manufacturing Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Contract Pharmaceutical Manufacturing Players by Revenue (US$ Million) in 2024
Table 13. Global Contract Pharmaceutical Manufacturing Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Contract Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2024)
Table 15. Global Contract Pharmaceutical Manufacturing Companies Headquarters
Table 16. Date of International Companies Enter into Contract Pharmaceutical Manufacturing Market
Table 17. Global Contract Pharmaceutical Manufacturing Companies Product & Service
Table 18. Global Contract Pharmaceutical Manufacturing Mergers & Acquisitions, Expansion Plans
Table 19. Catalent Corporation Information
Table 20. Catalent Description and Business Overview
Table 21. Catalent Contract Pharmaceutical Manufacturing Product
Table 22. Catalent Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 24. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 25. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 26. Catalent Recent Developments
Table 27. DPx Corporation Information
Table 28. DPx Description and Business Overview
Table 29. DPx Contract Pharmaceutical Manufacturing Product
Table 30. DPx Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 32. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 33. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 34. DPx Recent Developments
Table 35. Lonza Corporation Information
Table 36. Lonza Description and Business Overview
Table 37. Lonza Contract Pharmaceutical Manufacturing Product
Table 38. Lonza Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 40. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 41. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 42. Lonza Recent Developments
Table 43. Piramal Healthcare Corporation Information
Table 44. Piramal Healthcare Description and Business Overview
Table 45. Piramal Healthcare Contract Pharmaceutical Manufacturing Product
Table 46. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 48. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 49. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 50. Piramal Healthcare Recent Developments
Table 51. Aenova Corporation Information
Table 52. Aenova Description and Business Overview
Table 53. Aenova Contract Pharmaceutical Manufacturing Product
Table 54. Aenova Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 56. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 57. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 58. Aenova Recent Developments
Table 59. Jubilant Corporation Information
Table 60. Jubilant Description and Business Overview
Table 61. Jubilant Contract Pharmaceutical Manufacturing Product
Table 62. Jubilant Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 64. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 65. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 66. Jubilant Recent Developments
Table 67. Famar Corporation Information
Table 68. Famar Description and Business Overview
Table 69. Famar Contract Pharmaceutical Manufacturing Product
Table 70. Famar Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 72. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 73. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 74. Famar Recent Developments
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product
Table 78. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 80. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 81. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 82. Boehringer Ingelheim Recent Developments
Table 83. Fareva Holding Corporation Information
Table 84. Fareva Holding Description and Business Overview
Table 85. Fareva Holding Contract Pharmaceutical Manufacturing Product
Table 86. Fareva Holding Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 88. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 89. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 90. Fareva Holding Recent Developments
Table 91. AbbVie Corporation Information
Table 92. AbbVie Description and Business Overview
Table 93. AbbVie Contract Pharmaceutical Manufacturing Product
Table 94. AbbVie Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 96. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 97. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 98. AbbVie Recent Developments
Table 99. Nipro Corp Corporation Information
Table 100. Nipro Corp Description and Business Overview
Table 101. Nipro Corp Contract Pharmaceutical Manufacturing Product
Table 102. Nipro Corp Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 104. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 105. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 106. Nipro Corp Recent Developments
Table 107. Vetter Corporation Information
Table 108. Vetter Description and Business Overview
Table 109. Vetter Contract Pharmaceutical Manufacturing Product
Table 110. Vetter Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 112. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 113. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 114. Vetter Recent Developments
Table 115. Sopharma Corporation Information
Table 116. Sopharma Description and Business Overview
Table 117. Sopharma Contract Pharmaceutical Manufacturing Product
Table 118. Sopharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 120. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 121. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 122. Sopharma Recent Developments
Table 123. DPT Laboratories Corporation Information
Table 124. DPT Laboratories Description and Business Overview
Table 125. DPT Laboratories Contract Pharmaceutical Manufacturing Product
Table 126. DPT Laboratories Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 128. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 129. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 130. DPT Laboratories Recent Developments
Table 131. Recipharm Corporation Information
Table 132. Recipharm Description and Business Overview
Table 133. Recipharm Contract Pharmaceutical Manufacturing Product
Table 134. Recipharm Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 136. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 137. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 138. Recipharm Recent Developments
Table 139. NextPharma Corporation Information
Table 140. NextPharma Description and Business Overview
Table 141. NextPharma Contract Pharmaceutical Manufacturing Product
Table 142. NextPharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 144. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 145. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 146. NextPharma Recent Developments
Table 147. Dishman Corporation Information
Table 148. Dishman Description and Business Overview
Table 149. Dishman Contract Pharmaceutical Manufacturing Product
Table 150. Dishman Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 152. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 153. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 154. Dishman Recent Developments
Table 155. Aesica Corporation Information
Table 156. Aesica Description and Business Overview
Table 157. Aesica Contract Pharmaceutical Manufacturing Product
Table 158. Aesica Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 160. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 161. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 162. Aesica Recent Developments
Table 163. North America Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 183. Contract Pharmaceutical Manufacturing Key Raw Materials, Industry Status and Trend
Table 184. Contract Pharmaceutical Manufacturing Key Raw Materials and Upstream Suppliers
Table 185. Contract Pharmaceutical Manufacturing Clients Status and Trend
Table 186. Contract Pharmaceutical Manufacturing Typical Clients
Table 187. Contract Pharmaceutical Manufacturing Distributors
Table 188. Contract Pharmaceutical Manufacturing Market Trends
Table 189. Contract Pharmaceutical Manufacturing Market Drivers
Table 190. Contract Pharmaceutical Manufacturing Market Challenges
Table 191. Contract Pharmaceutical Manufacturing Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Contract Pharmaceutical Manufacturing Product Picture
Figure 2. Global Contract Pharmaceutical Manufacturing Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type in 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Injectable Product Picture
Figure 6. API Product Picture
Figure 7. Other Product Picture
Figure 8. Global Contract Pharmaceutical Manufacturing Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application in 2024 & 2031
Figure 10. Large Enterprise
Figure 11. Small Medium Enterprise
Figure 12. Contract Pharmaceutical Manufacturing Report Years Considered
Figure 13. Global Contract Pharmaceutical Manufacturing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Contract Pharmaceutical Manufacturing Market Size (2020-2031) & (US$ Million)
Figure 15. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2020-2031)
Figure 17. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Oral of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 20. Injectable of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 21. API of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 22. Other of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 23. Contract Pharmaceutical Manufacturing Revenue Share by Company (2024)
Figure 24. Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Oral Revenue Proportion by Company in 2024
Figure 26. Injectable Revenue Proportion by Company in 2024
Figure 27. API Revenue Proportion by Company in 2024
Figure 28. Other Revenue Proportion by Company in 2024
Figure 29. North America Contract Pharmaceutical Manufacturing Revenue 2020-2031 (US$ Million)
Figure 30. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 31. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 36. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2020-2031)
Figure 38. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 39. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 48. Contract Pharmaceutical Manufacturing Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Contract Pharmaceutical Manufacturing Raw Materials by Region in 2024
Figure 50. Contract Pharmaceutical Manufacturing Distribution Channels
Figure 51. Global Contract Pharmaceutical Manufacturing Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Contract Pharmaceutical Manufacturing Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Contract Pharmaceutical Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Contract Pharmaceutical Manufacturing Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Contract Pharmaceutical Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Contract Pharmaceutical Manufacturing Revenue by Company (2020-2025) & (US$ Million)
Table 11. Contract Pharmaceutical Manufacturing Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Contract Pharmaceutical Manufacturing Players by Revenue (US$ Million) in 2024
Table 13. Global Contract Pharmaceutical Manufacturing Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Contract Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2024)
Table 15. Global Contract Pharmaceutical Manufacturing Companies Headquarters
Table 16. Date of International Companies Enter into Contract Pharmaceutical Manufacturing Market
Table 17. Global Contract Pharmaceutical Manufacturing Companies Product & Service
Table 18. Global Contract Pharmaceutical Manufacturing Mergers & Acquisitions, Expansion Plans
Table 19. Catalent Corporation Information
Table 20. Catalent Description and Business Overview
Table 21. Catalent Contract Pharmaceutical Manufacturing Product
Table 22. Catalent Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 24. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 25. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 26. Catalent Recent Developments
Table 27. DPx Corporation Information
Table 28. DPx Description and Business Overview
Table 29. DPx Contract Pharmaceutical Manufacturing Product
Table 30. DPx Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 32. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 33. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 34. DPx Recent Developments
Table 35. Lonza Corporation Information
Table 36. Lonza Description and Business Overview
Table 37. Lonza Contract Pharmaceutical Manufacturing Product
Table 38. Lonza Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 40. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 41. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 42. Lonza Recent Developments
Table 43. Piramal Healthcare Corporation Information
Table 44. Piramal Healthcare Description and Business Overview
Table 45. Piramal Healthcare Contract Pharmaceutical Manufacturing Product
Table 46. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 48. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 49. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 50. Piramal Healthcare Recent Developments
Table 51. Aenova Corporation Information
Table 52. Aenova Description and Business Overview
Table 53. Aenova Contract Pharmaceutical Manufacturing Product
Table 54. Aenova Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 56. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 57. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 58. Aenova Recent Developments
Table 59. Jubilant Corporation Information
Table 60. Jubilant Description and Business Overview
Table 61. Jubilant Contract Pharmaceutical Manufacturing Product
Table 62. Jubilant Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 64. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 65. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 66. Jubilant Recent Developments
Table 67. Famar Corporation Information
Table 68. Famar Description and Business Overview
Table 69. Famar Contract Pharmaceutical Manufacturing Product
Table 70. Famar Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 72. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 73. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 74. Famar Recent Developments
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product
Table 78. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 80. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 81. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 82. Boehringer Ingelheim Recent Developments
Table 83. Fareva Holding Corporation Information
Table 84. Fareva Holding Description and Business Overview
Table 85. Fareva Holding Contract Pharmaceutical Manufacturing Product
Table 86. Fareva Holding Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 88. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 89. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 90. Fareva Holding Recent Developments
Table 91. AbbVie Corporation Information
Table 92. AbbVie Description and Business Overview
Table 93. AbbVie Contract Pharmaceutical Manufacturing Product
Table 94. AbbVie Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 96. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 97. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 98. AbbVie Recent Developments
Table 99. Nipro Corp Corporation Information
Table 100. Nipro Corp Description and Business Overview
Table 101. Nipro Corp Contract Pharmaceutical Manufacturing Product
Table 102. Nipro Corp Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 104. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 105. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 106. Nipro Corp Recent Developments
Table 107. Vetter Corporation Information
Table 108. Vetter Description and Business Overview
Table 109. Vetter Contract Pharmaceutical Manufacturing Product
Table 110. Vetter Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 112. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 113. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 114. Vetter Recent Developments
Table 115. Sopharma Corporation Information
Table 116. Sopharma Description and Business Overview
Table 117. Sopharma Contract Pharmaceutical Manufacturing Product
Table 118. Sopharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 120. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 121. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 122. Sopharma Recent Developments
Table 123. DPT Laboratories Corporation Information
Table 124. DPT Laboratories Description and Business Overview
Table 125. DPT Laboratories Contract Pharmaceutical Manufacturing Product
Table 126. DPT Laboratories Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 128. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 129. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 130. DPT Laboratories Recent Developments
Table 131. Recipharm Corporation Information
Table 132. Recipharm Description and Business Overview
Table 133. Recipharm Contract Pharmaceutical Manufacturing Product
Table 134. Recipharm Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 136. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 137. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 138. Recipharm Recent Developments
Table 139. NextPharma Corporation Information
Table 140. NextPharma Description and Business Overview
Table 141. NextPharma Contract Pharmaceutical Manufacturing Product
Table 142. NextPharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 144. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 145. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 146. NextPharma Recent Developments
Table 147. Dishman Corporation Information
Table 148. Dishman Description and Business Overview
Table 149. Dishman Contract Pharmaceutical Manufacturing Product
Table 150. Dishman Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 152. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 153. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 154. Dishman Recent Developments
Table 155. Aesica Corporation Information
Table 156. Aesica Description and Business Overview
Table 157. Aesica Contract Pharmaceutical Manufacturing Product
Table 158. Aesica Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2024
Table 160. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2024
Table 161. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2024
Table 162. Aesica Recent Developments
Table 163. North America Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 183. Contract Pharmaceutical Manufacturing Key Raw Materials, Industry Status and Trend
Table 184. Contract Pharmaceutical Manufacturing Key Raw Materials and Upstream Suppliers
Table 185. Contract Pharmaceutical Manufacturing Clients Status and Trend
Table 186. Contract Pharmaceutical Manufacturing Typical Clients
Table 187. Contract Pharmaceutical Manufacturing Distributors
Table 188. Contract Pharmaceutical Manufacturing Market Trends
Table 189. Contract Pharmaceutical Manufacturing Market Drivers
Table 190. Contract Pharmaceutical Manufacturing Market Challenges
Table 191. Contract Pharmaceutical Manufacturing Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Contract Pharmaceutical Manufacturing Product Picture
Figure 2. Global Contract Pharmaceutical Manufacturing Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type in 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Injectable Product Picture
Figure 6. API Product Picture
Figure 7. Other Product Picture
Figure 8. Global Contract Pharmaceutical Manufacturing Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application in 2024 & 2031
Figure 10. Large Enterprise
Figure 11. Small Medium Enterprise
Figure 12. Contract Pharmaceutical Manufacturing Report Years Considered
Figure 13. Global Contract Pharmaceutical Manufacturing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Contract Pharmaceutical Manufacturing Market Size (2020-2031) & (US$ Million)
Figure 15. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2020-2031)
Figure 17. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Oral of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 20. Injectable of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 21. API of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 22. Other of Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2024 VS 2031
Figure 23. Contract Pharmaceutical Manufacturing Revenue Share by Company (2024)
Figure 24. Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Oral Revenue Proportion by Company in 2024
Figure 26. Injectable Revenue Proportion by Company in 2024
Figure 27. API Revenue Proportion by Company in 2024
Figure 28. Other Revenue Proportion by Company in 2024
Figure 29. North America Contract Pharmaceutical Manufacturing Revenue 2020-2031 (US$ Million)
Figure 30. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 31. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 36. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2020-2031)
Figure 38. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 39. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2020-2025)
Figure 48. Contract Pharmaceutical Manufacturing Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Contract Pharmaceutical Manufacturing Raw Materials by Region in 2024
Figure 50. Contract Pharmaceutical Manufacturing Distribution Channels
Figure 51. Global Contract Pharmaceutical Manufacturing Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Contract Pharmaceutical Manufacturing Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232